Efficacy and safety of the betamethasone valerate 0.1 plaster in mild-to-moderate chronic plaque psoriasis: A randomized, parallel-group, active-controlled, phase III study

American Journal of Clinical Dermatology

Volumn 12, Issue 3, 2011, Pages 191-201

  Naldi, Luigi ^a   Yawalkar, Nikhil ^b   Kaszuba, Andrzej ^c   Ortonne, Jean Paul ^d   Morelli, Paolo ^e   Rovati, Stefano ^f   Mautone, Giuseppe ^f  

^a OSPEDALI RIUNITI   (Italy)

^b UNIVERSITY OF BERN   (Switzerland)

^c DERMED Specialist Outpatient Clinic   (Poland)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^e Cros NT   (Italy)

^f IBSA Institut Biochimique SA   (Switzerland)

Author keywords

adverse reactions; Betamethasone valerate; Corticosteroids; Plaque psoriasis; therapeutic use; Topical; treatment

Indexed keywords

BETAMETHASONE VALERATE;

ABDOMINAL PAIN; ADULT; ANALYSIS OF COVARIANCE; ARTHRALGIA; ARTICLE; ASTHMA; BACKACHE; BROCHITIS; BRONCHITIS; CHRONIC DISEASE; CLINICAL EVALUATION; CONTACT DERMATITIS; CONTROLLED STUDY; COUGHING; CREAM; DIGITAL IMAGING; DISEASE COURSE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ELBOW; ERYSIPELAS; FEMALE; FOLLICULITIS; FOLLOW UP; GASTROENTERITIS; GINGIVITIS; HEADACHE; HERPES INFE; HERPES SIMPLEX; HUMAN; HYPERTRICHOSIS; INNER EAR DISEASE; KNEE; MAJOR CLINICAL STUDY; MALE; MOUTH PAIN; NASIOPHARYNGITIS; NECK PAIN; OCCUPATIONAL ASTHMA; PATHOLOGIC FRACTURE; PATIENT SATISFACTION; PHARYNGITIS; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RHINITIS; RHINOPHARYNGITIS; SCREENING; SIDE EFFECT; SKIN ATROPHY; STREPTOCOCCUS PYOGENES; TOOTH PAIN; VIRAL RHINITIS;

ADMINISTRATION, CUTANEOUS; ADULT; BETAMETHASONE 17-VALERATE; DELAYED-ACTION PREPARATIONS; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; OCCLUSIVE DRESSINGS; PROSPECTIVE STUDIES; PSORIASIS; RECURRENCE; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 79953776852     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/11539780-000000000-00000     Document Type: Article

References (15)

1. Greaves MW, Weinstein GD. Treatment of psoriasis. N Engl JMed 1995 Mar 2; 332 (9): 581-8
2. Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 3, guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol 2009 Apr; 60 (4): 643-59
3. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet 2007 Jul 21; 370 (9583): 263-71 (Pubitemid 47069537)
4. Mason AR, Mason J, Cork M, et al. Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev 2009; (2): CD005028
5. Federman DG, Froelich CW, Kirsner RS. Topical psoriasis therapy. Am Fam Physician 1999 Feb 15; 59 (4): 957-62, 64 (Pubitemid 29108614)
6. Afifi T, de Gannes G, Huang C, et al. Topical therapies for psoriasis: evidencebased review. Can Fam Physician 2005 Apr; 51: 519-25 (Pubitemid 40528840)
7. IBSA Institut Biochimique SA. Betesil 2.25 mg medicated plaster; 2009 [online]. Available from URL: http://www.ibsa.ch/welcome-intl/ productsdermatology-betesil-intl.htm?id=1244 [Accessed 2011 Jan 6]
8. European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP): guideline on clinical investigation of medicinal products indicated for the treatment of psoriasis [online]. Available from URL: http://www.ema.europa. eu/pdfs/human/ewp/245402en.pdf [Accessed 2011 Jan 6]
9. Betneval® 0.1% cream (package insert) [online]. Available from URL: http:// www.gsk.fr/gsk/medicament/notice/Betneval.pdf [Accessed 2011 Jan 6]
10. Wilkinson RD, OhayonM. Therapeutic response to a dermatologic patch and betamethasone valerate 0.1 percent cream in the management of chronic plaques in psoriasis. Cutis 1990 Jun; 45 (6): 468-70 (Pubitemid 20177644)
11. Pacifico A, Daidone R, Peris K. A new formulation of an occlusive dressing containing betamethasone valerate 0.1%in the treatment of mild to moderate psoriasis. J Eur Acad Dermatol Venereol 2006 Feb; 20 (2): 153-7 (Pubitemid 43740514)
12. Actiderm Multi-Center Study Group. A trial of the Actiderm dermatological patch and topical corticosteroids in the treatment of psoriasis vulgaris. Cutis 1990 Jul; 46 (1): 84-8
13. Broby-Johansen U, Karlsmark T, Petersen LJ, et al. Ranking of the antipsoriatic effect of various topical corticosteroids applied under a hydrocolloid dressing: skin-thickness, blood-flow and colour measurements compared to clinical assessments. Clin Exp Dermatol 1990 Sep; 15 (5): 343-8 (Pubitemid 20277335)
14. Volden G, Kragballe K, Van De Kerkhof PC, et al. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone. J Dermatolog Treat 2001 Sep; 12 (3): 141-4 (Pubitemid 33116875)
15. van der Vleuten CJ, van Vlijmen-Willems IM, de Jong EM, et al. Clobetasol-17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly versus unoccluded clobetasol-17-propionate ointment twice daily in psoriasis: an immunohistochemical study on remission and relapse. Arch Dermatol Res 1999 Jul-Aug; 291 (7-8): 390-5 (Pubitemid 29396826)